The pharmaceutical business made yet another attempt to protect the world's forests when it sent a letter to a special committee of the European Parliament in late April. The letter was presented by the Council for Economic Education.The letter said that without the plants and trees that serve as the foundation for many current therapies, the pharmaceutical industry would be unable to develop new ones and requested funding for poor nations.
As a result, businesses attempting to lessen their carbon impact ship the majority of their products to the EU, a sizable export market.
This appears to have a lot of fine print.However, the issue of how to lower greenhouse gas emissions at the EU level is hidden by pharmaceutical companies' long-distance shipping routes, which concentrate on the production and distribution of chemicals.